Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

National practice trends for the surgical management of lung cancer in the CMS population: an atlas of care.

Phillips JD, Bostock IC, Hasson RM, Goodney PP, Goodman DC, Millington TM, Finley DJ.

J Thorac Dis. 2019 Mar;11(Suppl 4):S500-S508. doi: 10.21037/jtd.2019.01.05.

2.

Reply to the Editor- Leftward on left anterior oblique is not always septal!

Iribarne A, Sangha RS, Bostock IC, Rothstein ES, McCullough JN.

HeartRhythm Case Rep. 2018 Sep 17;4(12):605. doi: 10.1016/j.hrcr.2018.08.014. eCollection 2018 Dec. No abstract available.

3.

Extending endovascular aneurysm repair to more patients without better outcomes.

Zarkowsky DS, Hicks CW, Bostock IC, Malas MB, Goodney PP.

J Vasc Surg. 2019 May;69(5):1412-1420.e1. doi: 10.1016/j.jvs.2018.08.170. Epub 2018 Nov 26.

PMID:
30497862
4.

Contemporary outcomes of surgical management of complex thoracic infections.

Bostock IC, Sheikh F, Millington TM, Finley DJ, Phillips JD.

J Thorac Dis. 2018 Sep;10(9):5421-5427. doi: 10.21037/jtd.2018.08.43.

5.

Right ventricular lead perforation through the septum, left ventricle, and pleura, managed by an open surgical approach.

Iribarne A, Sangha RS, Bostock IC, Rothstein ES, McCullough JN.

HeartRhythm Case Rep. 2018 May 23;4(9):397-400. doi: 10.1016/j.hrcr.2018.05.004. eCollection 2018 Sep. No abstract available.

6.

Outcomes and Risk Factors Associated with Prolonged Intubation after EVAR.

Bostock IC, Zarkowsky DS, Hicks CW, Stone DH, Malas MB, Goodney PP.

Ann Vasc Surg. 2018 Jul;50:167-172. doi: 10.1016/j.avsg.2017.11.063. Epub 2018 Feb 23.

PMID:
29481928
7.

Outcomes with moderate aortic stenosis and impaired left ventricular function: prelude to a randomized trial?

Iribarne A, Easterwood RM, Bostock IC, McCullough JN.

J Thorac Dis. 2017 Oct;9(10):3529-3532. doi: 10.21037/jtd.2017.09.16. No abstract available.

8.

Mortality after emergency Hartmann's procedure in octogenarians: a propensity score-matched analysis.

Bostock IC, Hill MV, Counihan TC, Ivatury SJ.

J Surg Res. 2018 Jan;221:167-172. doi: 10.1016/j.jss.2017.08.030. Epub 2017 Sep 23.

PMID:
29229124
9.

The evolution of minimally invasive cardiac surgery: from minimal access to transcatheter approaches.

Easterwood RM, Bostock IC, Nammalwar S, McCullough JN, Iribarne A.

Future Cardiol. 2018 Jan;14(1):75-87. doi: 10.2217/fca-2017-0048. Epub 2017 Dec 4. Review.

PMID:
29199850
10.

Intensive care unit admission after endovascular aortic aneurysm repair is primarily determined by hospital factors, adds significant cost, and is often unnecessary.

Hicks CW, Alshaikh HN, Zarkowsky D, Bostock IC, Nejim B, Malas MB.

J Vasc Surg. 2018 Apr;67(4):1091-1101.e4. doi: 10.1016/j.jvs.2017.07.139. Epub 2017 Oct 23.

PMID:
29074117
11.

Optimal revascularization for left main coronary artery disease-coronary artery bypass grafting versus percutaneous coronary intervention.

Bostock IC, McCullough JN, Iribarne A.

J Thorac Dis. 2017 May;9(5):1171-1173. doi: 10.21037/jtd.2017.04.24. No abstract available.

12.

Aneurysmosis requiring extensive longitudinal care.

Ferm S, Zarkowsky DS, Bostock I, Nolan B.

J Vasc Surg. 2017 May;65(5):1518. doi: 10.1016/j.jvs.2016.02.061. No abstract available.

13.

Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.

Alvarez Salazar EK, Cortés-Hernández A, Alemán-Muench GR, Alberú J, Rodríguez-Aguilera JR, Recillas-Targa F, Chagoya de Sánchez V, Cuevas E, Mancilla-Urrea E, Pérez García M, Mondragón-Ramírez G, Vilatobá M, Bostock I, Hernández-Méndez E, De Rungs D, García-Zepeda EA, Soldevila G.

Front Immunol. 2017 Mar 3;8:219. doi: 10.3389/fimmu.2017.00219. eCollection 2017.

14.

Endovascular aneurysm repair patients who are lost to follow-up have worse outcomes.

Hicks CW, Zarkowsky DS, Bostock IC, Stone DH, Black JH 3rd, Eldrup-Jorgensen J, Goodney PP, Malas MB.

J Vasc Surg. 2017 Jun;65(6):1625-1635. doi: 10.1016/j.jvs.2016.10.106. Epub 2017 Feb 16.

15.

Renal dysfunction and the associated decrease in survival after elective endovascular aneurysm repair.

Zarkowsky DS, Hicks CW, Bostock IC, Stone DH, Eslami M, Goodney PP.

J Vasc Surg. 2016 Nov;64(5):1278-1285.e1. doi: 10.1016/j.jvs.2016.04.009. Epub 2016 Jul 29.

16.

Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States.

Melamed A, Hinchcliff EM, Clemmer JT, Bregar AJ, Uppal S, Bostock I, Schorge JO, Del Carmen MG, Rauh-Hain JA.

Gynecol Oncol. 2016 Nov;143(2):236-240. doi: 10.1016/j.ygyno.2016.09.002. Epub 2016 Sep 6.

PMID:
27612977
17.

Outcomes of Endovascular Aortic Aneurysm Repair in Kidney Transplant Recipients: Results From a National Quality Initiative.

Bostock IC, Zarkowsky DS, Hicks CW, Stone DH, Eslami MH, Malas MB, Goodney PP.

Am J Transplant. 2016 Aug;16(8):2395-400. doi: 10.1111/ajt.13733. Epub 2016 Mar 31.

18.

A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation.

Roedder S, Li L, Alonso MN, Hsieh SC, Vu MT, Dai H, Sigdel TK, Bostock I, Macedo C, Metes D, Zeevi A, Shapiro R, Salvatierra O, Scandling J, Alberu J, Engleman E, Sarwal MM.

J Am Soc Nephrol. 2015 Aug;26(8):2042-53. doi: 10.1681/ASN.2013111239. Epub 2014 Nov 26.

19.

Renal transplant recipient with advanced HIV infection: graft and peripheral cell population analysis.

Bostock IC, Furuzawa-Carballeda J, Gómez-Martín D, Lima G, Martin-Onraët A, Sierra J, Uribe-Uribe NO, Vilatobá M, Contreras AG, Gabilondo B, Morales-Buenrostro LE, Alberú J.

Clin Case Rep. 2013 Dec;1(2):79-85. doi: 10.1002/ccr3.28. Epub 2013 Nov 18.

20.

Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.

Furuzawa-Carballeda J, Bostock IC, Lima G, Mancilla-Urrea E, Mondragón G, Reyes-Acevedo R, Chevaile A, Morales-Buenrostro LE, Llorente L, Alberú J.

Transpl Immunol. 2014 Mar;30(2-3):107-13. doi: 10.1016/j.trim.2014.02.002. Epub 2014 Feb 18.

PMID:
24561014
21.

Fever, haematuria, and acute graft dysfunction in renal transplant recipients secondary to adenovirus infection: two case reports.

Ramírez J, Bostock IC, Martin-Onraët A, Calleja S, Sánchez-Cedillo A, Navarro-Vargas LA, Noriega-Salas AL, Martínez-Mijangos O, Uribe-Uribe NO, Vilatoba M, Gabilondo B, Morales-Buenrostro LE, Alberú J.

Case Rep Nephrol. 2013;2013:195753. doi: 10.1155/2013/195753. Epub 2013 Feb 14.

22.

Probability of deceased donor kidney transplantation based on % PRA.

Bostock IC, Alberú J, Arvizu A, Hernández-Mendez EA, De-Santiago A, González-Tableros N, López M, Castelán N, Contreras AG, Morales-Buenrostro LE, Gabilondo B, Vilatobá M.

Transpl Immunol. 2013 Jun;28(4):154-8. doi: 10.1016/j.trim.2013.05.002. Epub 2013 May 16.

23.

Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.

Furuzawa-Carballeda J, Lima G, Simancas P, Ramos-Bello D, Simancas M, Bostock IC, Vilatobá M, Gabilondo B, Granados J, Morales-Buenrostro L, Alberú J, Llorente L.

J Transplant. 2012;2012:256960. doi: 10.1155/2012/256960. Epub 2012 Nov 19.

24.

Analysis of a quantity of fluid drawn off from a Hydrocele of some years' standing.

Bostock I.

Med Chir Trans. 1829;15(Pt 1):154-60. No abstract available.

Supplemental Content

Loading ...
Support Center